Youngy Health Co., Ltd. (300247.SZ)
CNY 3.61
(-0.28%)
CNY 3.61
(-0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 90.39 Million CNY | -42.41% |
| 2022 | 167.69 Million CNY | 181.75% |
| 2021 | 61.16 Million CNY | 272.17% |
| 2020 | -26.21 Million CNY | -25.36% |
| 2019 | -698.65 Million CNY | -135.2% |
| 2018 | -743.68 Million CNY | -65.89% |
| 2017 | 114.27 Million CNY | 38.94% |
| 2016 | 136.08 Million CNY | 101.2% |
| 2015 | 77.16 Million CNY | 80.01% |
| 2014 | 43.4 Million CNY | 24.82% |
| 2013 | 35.09 Million CNY | 10.21% |
| 2012 | 32.14 Million CNY | -47.31% |
| 2011 | 60.36 Million CNY | 6.74% |
| 2010 | 57.97 Million CNY | 27.09% |
| 2009 | 45.13 Million CNY | 28.75% |
| 2008 | 33.48 Million CNY | 75.35% |
| 2007 | 20.28 Million CNY | 0.49% |
| 2006 | 20.17 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 24.11 Million CNY | 176.55% |
| 2024 Q3 | 8.32 Million CNY | -45.17% |
| 2024 Q2 | 15.17 Million CNY | -65.29% |
| 2023 Q3 | -18.42 Million CNY | -172.52% |
| 2023 FY | - CNY | -42.41% |
| 2023 Q4 | 43.12 Million CNY | 334.06% |
| 2023 Q2 | 25.4 Million CNY | 47.8% |
| 2023 Q1 | 17.18 Million CNY | -87.92% |
| 2022 Q2 | 132.04 Million CNY | 692.5% |
| 2022 Q1 | 16.66 Million CNY | -64.33% |
| 2022 Q3 | -153.99 Million CNY | -216.62% |
| 2022 FY | - CNY | 181.75% |
| 2022 Q4 | 142.32 Million CNY | 192.42% |
| 2021 Q2 | 4.69 Million CNY | -35.79% |
| 2021 Q3 | -22.61 Million CNY | -581.44% |
| 2021 Q1 | 7.31 Million CNY | 129.03% |
| 2021 FY | - CNY | 272.17% |
| 2021 Q4 | 46.7 Million CNY | 306.53% |
| 2020 FY | - CNY | -25.36% |
| 2020 Q3 | -24.61 Million CNY | -359.52% |
| 2020 Q2 | 9.48 Million CNY | 176.8% |
| 2020 Q1 | -12.35 Million CNY | 64.95% |
| 2020 Q4 | -25.2 Million CNY | -2.38% |
| 2019 FY | - CNY | -135.2% |
| 2019 Q4 | -35.23 Million CNY | -476.82% |
| 2019 Q2 | -12.24 Million CNY | 38.95% |
| 2019 Q1 | -20.05 Million CNY | -95.12% |
| 2019 Q3 | 9.35 Million CNY | 176.36% |
| 2018 Q3 | 17.52 Million CNY | -0.02% |
| 2018 FY | - CNY | -65.89% |
| 2018 Q1 | 22.09 Million CNY | -82.83% |
| 2018 Q4 | -10.28 Million CNY | -158.67% |
| 2018 Q2 | 17.52 Million CNY | -20.68% |
| 2017 FY | - CNY | 38.94% |
| 2017 Q4 | 128.68 Million CNY | 344.39% |
| 2017 Q1 | 18.13 Million CNY | -84.35% |
| 2017 Q2 | 28.44 Million CNY | 56.83% |
| 2017 Q3 | 28.95 Million CNY | 1.8% |
| 2016 FY | - CNY | 101.2% |
| 2016 Q3 | 13.46 Million CNY | -29.1% |
| 2016 Q4 | 115.86 Million CNY | 760.42% |
| 2016 Q2 | 18.99 Million CNY | 228.06% |
| 2016 Q1 | 5.78 Million CNY | -85.36% |
| 2015 Q1 | 10.35 Million CNY | -19.26% |
| 2015 Q2 | 7.53 Million CNY | -27.23% |
| 2015 Q3 | 1.24 Million CNY | -83.43% |
| 2015 Q4 | 39.53 Million CNY | 3068.26% |
| 2015 FY | - CNY | 80.01% |
| 2014 Q1 | 6.77 Million CNY | -23.32% |
| 2014 FY | - CNY | 24.82% |
| 2014 Q2 | 9.23 Million CNY | 36.34% |
| 2014 Q3 | 1.34 Million CNY | -85.41% |
| 2014 Q4 | 12.82 Million CNY | 851.5% |
| 2013 Q4 | 8.83 Million CNY | 384.38% |
| 2013 FY | - CNY | 10.21% |
| 2013 Q1 | 7.75 Million CNY | -56.92% |
| 2013 Q3 | 1.82 Million CNY | -71.97% |
| 2013 Q2 | 6.5 Million CNY | -16.19% |
| 2012 Q4 | 18.01 Million CNY | 2666.27% |
| 2012 Q3 | -701.87 Thousand CNY | -128.29% |
| 2012 Q2 | 2.48 Million CNY | -49.56% |
| 2012 FY | - CNY | -47.31% |
| 2012 Q1 | 4.91 Million CNY | -76.06% |
| 2011 FY | - CNY | 6.74% |
| 2011 Q4 | 20.54 Million CNY | 60.0% |
| 2011 Q3 | 12.84 Million CNY | 9.34% |
| 2011 Q2 | 11.74 Million CNY | 7.98% |
| 2011 Q1 | 10.87 Million CNY | -40.69% |
| 2010 Q4 | 18.33 Million CNY | 14.32% |
| 2010 Q3 | 16.03 Million CNY | 0.0% |
| 2010 FY | - CNY | 27.09% |
| 2009 FY | - CNY | 28.75% |
| 2008 FY | - CNY | 75.35% |
| 2007 FY | - CNY | 0.49% |
| 2006 FY | - CNY | 0.0% |